Skip to main content
Top
Published in: Archives of Dermatological Research 5/2024

Open Access 01-07-2024 | Rosacea | REVIEW

The role of vitamins and nutrients in rosacea

Authors: Yanci A. Algarin, Anika Pulumati, Dana Jaalouk, Jiali Tan, Keyvan Nouri

Published in: Archives of Dermatological Research | Issue 5/2024

Login to get access

Abstract

Rosacea is a common inflammatory skin condition displaying symptoms like flushing, erythema, papules, and pustules. Oral antibiotics, despite long-term adverse effects, are often used due to topical treatment limitations, underscoring the need for cost-effective choices like dietary modifications. Our review investigates the role of vitamins and minerals in rosacea, and provides evidence-based recommendations for supplementation and topical treatment of these nutrients for rosacea. An online search was performed on PubMed, Web of Science, Science Direct, Google Scholar, and ClinicalTrials.gov from 1998 to 2023. Included studies were summarized and assessed for quality and relevance in rosacea management. Varied outcomes emerged concerning the impact of essential vitamins and minerals on rosacea treatment. Vitamin A derivatives, specifically oral isotretinoin, demonstrated significant efficacy, with a 90% reduction in lesions, complete remission in 24% of patients, and marked improvement in 57% of patients. Vitamin B3 derivatives, such as topical 1-methylnicotinamide 0.25% and NADH 1%, improved symptoms in 76.4% (26/34) and 80% of patients, respectively. Outcomes for vitamin D, vitamin C, and zinc supplementation varied across studies. However, zinc sulfate solution 5% significantly reduced acne rosacea severity for patients with 40% and 60% exhibiting a moderate or good response, respectively. Omega-3 fatty acids showed significant improvement in alleviating xerophthalmia in 64% of patients with ocular rosacea. Vitamins and minerals hold potential in managing rosacea symptoms, offering a safe and cost-effective alternative or adjunctive treatment option. Currently, there are no established recommendations regarding their supplementation for rosacea. Studies assessing serum levels of vitamins and minerals in relation to rosacea are warranted, as this avenue holds potential for future advancements in the field.
Literature
1.
go back to reference Rainer BM, Fischer AH, da Luz Felipe Silva D, Kang S, Chien AL (2015) Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 73(4):604–8PubMedCrossRef Rainer BM, Fischer AH, da Luz Felipe Silva D, Kang S, Chien AL (2015) Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 73(4):604–8PubMedCrossRef
2.
go back to reference Tan J, Schöfer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M et al (2016) Prevalence of rosacea in the general population of Germany and Russia—The RISE study. J Eur Acad Dermatol Venereol JEADV 30(3):428–434PubMedCrossRef Tan J, Schöfer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M et al (2016) Prevalence of rosacea in the general population of Germany and Russia—The RISE study. J Eur Acad Dermatol Venereol JEADV 30(3):428–434PubMedCrossRef
3.
go back to reference van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J (2021) Rosacea: new concepts in classification and treatment. Am J Clin Dermatol 22(4):457–465PubMedPubMedCentralCrossRef van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J (2021) Rosacea: new concepts in classification and treatment. Am J Clin Dermatol 22(4):457–465PubMedPubMedCentralCrossRef
5.
go back to reference Two AM, Wu W, Gallo RL, Hata TR (2015) Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 72(5):749–58 (Quiz 759–60)PubMedCrossRef Two AM, Wu W, Gallo RL, Hata TR (2015) Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 72(5):749–58 (Quiz 759–60)PubMedCrossRef
6.
go back to reference Schaller M, Schöfer H, Homey B, Hofmann M, Gieler U, Lehmann P et al (2016) Rosacea management: update on general measures and topical treatment options. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 14(Suppl 6):17–27 Schaller M, Schöfer H, Homey B, Hofmann M, Gieler U, Lehmann P et al (2016) Rosacea management: update on general measures and topical treatment options. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 14(Suppl 6):17–27
7.
go back to reference Mrowietz U, Kedem TH, Keynan R, Eini M, Tamarkin D, Rom D et al (2018) A phase ii, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular Rosacea. Am J Clin Dermatol 19(3):427–436PubMedCrossRef Mrowietz U, Kedem TH, Keynan R, Eini M, Tamarkin D, Rom D et al (2018) A phase ii, randomized, double-blind clinical study evaluating the safety, tolerability, and efficacy of a topical minocycline foam, FMX103, for the treatment of facial papulopustular Rosacea. Am J Clin Dermatol 19(3):427–436PubMedCrossRef
8.
go back to reference Gold LS, Del Rosso JQ, Kircik L, Bhatia ND, Hooper D, Nahm WK et al (2020) Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials. J Am Acad Dermatol. 82(5):1166–73PubMedCrossRef Gold LS, Del Rosso JQ, Kircik L, Bhatia ND, Hooper D, Nahm WK et al (2020) Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: results of 2 phase 3, randomized, clinical trials. J Am Acad Dermatol. 82(5):1166–73PubMedCrossRef
9.
go back to reference Jamgochian M, Alamgir M, Rao B (2023) Diet in dermatology: review of diet’s influence on the conditions of rosacea, hidradenitis suppurativa, herpes labialis, and vitiligo. Am J Lifestyle Med 17(1):152–160PubMedCrossRef Jamgochian M, Alamgir M, Rao B (2023) Diet in dermatology: review of diet’s influence on the conditions of rosacea, hidradenitis suppurativa, herpes labialis, and vitiligo. Am J Lifestyle Med 17(1):152–160PubMedCrossRef
11.
go back to reference Alia E, Feng H (2022) Rosacea pathogenesis, common triggers, and dietary role: the cause, the trigger, and the positive effects of different foods. Clin Dermatol 40(2):122–127PubMedCrossRef Alia E, Feng H (2022) Rosacea pathogenesis, common triggers, and dietary role: the cause, the trigger, and the positive effects of different foods. Clin Dermatol 40(2):122–127PubMedCrossRef
14.
go back to reference Pelle MT, Crawford GH, James WD (2004) Rosacea: II therapy. J Am Acad Dermatol. 51(4):499–512 (Quiz 513–4)PubMedCrossRef Pelle MT, Crawford GH, James WD (2004) Rosacea: II therapy. J Am Acad Dermatol. 51(4):499–512 (Quiz 513–4)PubMedCrossRef
15.
go back to reference Anzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yawalkar N, Häusermann P et al (2017) Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol JEADV 31(11):1775–1791PubMedCrossRef Anzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yawalkar N, Häusermann P et al (2017) Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol JEADV 31(11):1775–1791PubMedCrossRef
16.
go back to reference Schmidt JB, Gebhart W, Raff M, Spona J (1984) 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol. 64(1):15–21PubMedCrossRef Schmidt JB, Gebhart W, Raff M, Spona J (1984) 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol. 64(1):15–21PubMedCrossRef
17.
go back to reference Plewig G, Nikolowski J, Wolff HH (1982) Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol. 6(4 Pt 2 Suppl):766–85PubMedCrossRef Plewig G, Nikolowski J, Wolff HH (1982) Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol. 6(4 Pt 2 Suppl):766–85PubMedCrossRef
18.
go back to reference Hoting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25(10):660–663PubMedCrossRef Hoting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25(10):660–663PubMedCrossRef
19.
go back to reference Marsden JR, Shuster S, Neugebauer M (1984) Response of rosacea to isotretinoin. Clin Exp Dermatol 9(5):484–488PubMedCrossRef Marsden JR, Shuster S, Neugebauer M (1984) Response of rosacea to isotretinoin. Clin Exp Dermatol 9(5):484–488PubMedCrossRef
20.
go back to reference Chang ALS, Alora-Palli M, Lima XT, Chang TC, Cheng C, Chung CM et al (2012) A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. J Drugs Dermatol JDD. 11(3):333–9PubMed Chang ALS, Alora-Palli M, Lima XT, Chang TC, Cheng C, Chung CM et al (2012) A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. J Drugs Dermatol JDD. 11(3):333–9PubMed
21.
go back to reference Altinyazar HC, Koca R, Tekin NS, Eştürk E (2005) Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol. 44(3):252–5PubMedCrossRef Altinyazar HC, Koca R, Tekin NS, Eştürk E (2005) Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol. 44(3):252–5PubMedCrossRef
22.
go back to reference Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthetic Dermatol 4(9):54–61 Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthetic Dermatol 4(9):54–61
23.
go back to reference Gollnick H, Blume-Peytavi U, Szabó EL, Meyer KG, Hauptmann P, Popp G et al (2010) Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 8(7):505–515 Gollnick H, Blume-Peytavi U, Szabó EL, Meyer KG, Hauptmann P, Popp G et al (2010) Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 8(7):505–515
24.
go back to reference Hofer T (2004) Continuous, “microdose” isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol 29(2):204–205PubMedCrossRef Hofer T (2004) Continuous, “microdose” isotretinoin in adult recalcitrant rosacea. Clin Exp Dermatol 29(2):204–205PubMedCrossRef
25.
go back to reference de Oliveira CMM, Almeida LMC, Bonamigo RR, de Lima CWG, Bagatin E (2020) Consensus on the therapeutic management of rosacea—Brazilian Society of Dermatology. An Bras Dermatol. 95(Suppl 1):53–69PubMedPubMedCentralCrossRef de Oliveira CMM, Almeida LMC, Bonamigo RR, de Lima CWG, Bagatin E (2020) Consensus on the therapeutic management of rosacea—Brazilian Society of Dermatology. An Bras Dermatol. 95(Suppl 1):53–69PubMedPubMedCentralCrossRef
26.
go back to reference Tulipan L (1947) Acne rosacea; a vitamin B complex deficiency. Arch Dermatol Syphilol 56(5):589–591CrossRef Tulipan L (1947) Acne rosacea; a vitamin B complex deficiency. Arch Dermatol Syphilol 56(5):589–591CrossRef
27.
go back to reference Huang YW, Huang HP, Hsu CK, Lee JYY (2022) Hydroxocobalamin: an effective treatment for flushing and persistent erythema in rosacea. J Clin Aesthetic Dermatol 15(6):42–45 Huang YW, Huang HP, Hsu CK, Lee JYY (2022) Hydroxocobalamin: an effective treatment for flushing and persistent erythema in rosacea. J Clin Aesthetic Dermatol 15(6):42–45
28.
go back to reference Chung BY, Kim HO, Park CW, Yang NG, Kim JY, Eun YS et al (2022) Relationships of serum homocysteine, vitamin B12, and folic acid levels with papulopustular rosacea severity: a case-control study. BioMed Res Int 2022:5479626PubMedPubMedCentralCrossRef Chung BY, Kim HO, Park CW, Yang NG, Kim JY, Eun YS et al (2022) Relationships of serum homocysteine, vitamin B12, and folic acid levels with papulopustular rosacea severity: a case-control study. BioMed Res Int 2022:5479626PubMedPubMedCentralCrossRef
29.
go back to reference McKenney J (2003) Niacin for dyslipidemia: considerations in product selection. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 60(10):995–1005CrossRef McKenney J (2003) Niacin for dyslipidemia: considerations in product selection. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 60(10):995–1005CrossRef
30.
go back to reference Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM et al (2005) GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 115(12):3634–3640PubMedPubMedCentralCrossRef Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, Nüsing RM et al (2005) GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 115(12):3634–3640PubMedPubMedCentralCrossRef
31.
go back to reference Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M (2005) Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 44(3):197–202PubMedCrossRef Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M (2005) Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol 44(3):197–202PubMedCrossRef
32.
go back to reference Rolfe HM (2014) A review of nicotinamide: treatment of skin diseases and potential side effects. J Cosmet Dermatol 13(4):324–328PubMedCrossRef Rolfe HM (2014) A review of nicotinamide: treatment of skin diseases and potential side effects. J Cosmet Dermatol 13(4):324–328PubMedCrossRef
33.
go back to reference Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A (2005) Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol 30(6):632–635PubMedCrossRef Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A (2005) Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol 30(6):632–635PubMedCrossRef
34.
go back to reference Woźniacka A, Sysa-Jedrzejowska A, Adamus J, Gebicki J (2003) Topical application of NADH for the treatment of rosacea and contact dermatitis. Clin Exp Dermatol 28(1):61–63PubMedCrossRef Woźniacka A, Sysa-Jedrzejowska A, Adamus J, Gebicki J (2003) Topical application of NADH for the treatment of rosacea and contact dermatitis. Clin Exp Dermatol 28(1):61–63PubMedCrossRef
35.
go back to reference Jansen T, Romiti R, Kreuter A, Altmeyer P (2001) Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol JEADV 15(5):484–485PubMedCrossRef Jansen T, Romiti R, Kreuter A, Altmeyer P (2001) Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol JEADV 15(5):484–485PubMedCrossRef
36.
go back to reference Zhou SS, Li D, Sun WP, Guo M, Lun YZ, Zhou YM et al (2009) Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol 15(45):5674–5684PubMedPubMedCentralCrossRef Zhou SS, Li D, Sun WP, Guo M, Lun YZ, Zhou YM et al (2009) Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol 15(45):5674–5684PubMedPubMedCentralCrossRef
37.
go back to reference Kim NH, Kirsner RS (2010) Nicotinamide in dermatology. Expert Rev Dermatol 5(1):23–29CrossRef Kim NH, Kirsner RS (2010) Nicotinamide in dermatology. Expert Rev Dermatol 5(1):23–29CrossRef
39.
go back to reference Paul C, Brady DM (2017) Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms. Integr Med Encinitas Calif 16(1):42–49 Paul C, Brady DM (2017) Comparative bioavailability and utilization of particular forms of B12 supplements with potential to mitigate B12-related genetic polymorphisms. Integr Med Encinitas Calif 16(1):42–49
40.
go back to reference Kira J, Tobimatsu S, Goto I (1994) Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med Tokyo Jpn 33(2):82–86CrossRef Kira J, Tobimatsu S, Goto I (1994) Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med Tokyo Jpn 33(2):82–86CrossRef
41.
go back to reference Bodian M (1963) Neuroblastoma: an evaluation of its natural history and the effects of therapy, with particular reference to treatment by massive doses of vitamin B12. Arch Dis Child 38(202):606–619PubMedPubMedCentralCrossRef Bodian M (1963) Neuroblastoma: an evaluation of its natural history and the effects of therapy, with particular reference to treatment by massive doses of vitamin B12. Arch Dis Child 38(202):606–619PubMedPubMedCentralCrossRef
43.
go back to reference Park BW, Ha JM, Cho EB, Jin JK, Park EJ, Park HR et al (2018) A study on vitamin d and cathelicidin status in patients with rosacea: serum level and tissue expression. Ann Dermatol 30(2):136–142PubMedPubMedCentralCrossRef Park BW, Ha JM, Cho EB, Jin JK, Park EJ, Park HR et al (2018) A study on vitamin d and cathelicidin status in patients with rosacea: serum level and tissue expression. Ann Dermatol 30(2):136–142PubMedPubMedCentralCrossRef
44.
go back to reference Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB et al (2011) Antimicrobial implications of vitamin D. Dermatoendocrinol 3(4):220–229PubMedPubMedCentralCrossRef Youssef DA, Miller CW, El-Abbassi AM, Cutchins DC, Cutchins C, Grant WB et al (2011) Antimicrobial implications of vitamin D. Dermatoendocrinol 3(4):220–229PubMedPubMedCentralCrossRef
45.
go back to reference Akdogan N, Alli N, Incel Uysal P, Candar T (2019) Role of serum 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms in patients with rosacea: a case-control study. Clin Exp Dermatol 44(4):397–403PubMedCrossRef Akdogan N, Alli N, Incel Uysal P, Candar T (2019) Role of serum 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms in patients with rosacea: a case-control study. Clin Exp Dermatol 44(4):397–403PubMedCrossRef
46.
go back to reference Gürel G, Karadöl M, Çölgeçen E (2018) A case-control study on rosacea and vitamin D levels. J Surg Med 2(3):269–272 Gürel G, Karadöl M, Çölgeçen E (2018) A case-control study on rosacea and vitamin D levels. J Surg Med 2(3):269–272
47.
go back to reference Hagag MM, Bayomy NR, El-Horish DBM (2021) Study of vitamin D and calcium levels in patient with rosacea. Egypt J Hosp Med 84(1):2405–2410CrossRef Hagag MM, Bayomy NR, El-Horish DBM (2021) Study of vitamin D and calcium levels in patient with rosacea. Egypt J Hosp Med 84(1):2405–2410CrossRef
48.
go back to reference Mao R, Zhou G, Jing D, Liu H, Shen M, Li J (2023) Vitamin D status, vitamin D receptor polymorphisms, and the risk of incident rosacea: insights from mendelian randomization and cohort study in the UK biobank. Nutrients 15(17):3803PubMedPubMedCentralCrossRef Mao R, Zhou G, Jing D, Liu H, Shen M, Li J (2023) Vitamin D status, vitamin D receptor polymorphisms, and the risk of incident rosacea: insights from mendelian randomization and cohort study in the UK biobank. Nutrients 15(17):3803PubMedPubMedCentralCrossRef
49.
go back to reference Popa DS, Bigman G, Rusu ME (2021) The role of vitamin k in humans: implication in aging and age-associated diseases. Antioxid Basel Switz 10(4):566CrossRef Popa DS, Bigman G, Rusu ME (2021) The role of vitamin k in humans: implication in aging and age-associated diseases. Antioxid Basel Switz 10(4):566CrossRef
50.
go back to reference Pazyar N, Houshmand G, Yaghoobi R, Hemmati AA, Zeineli Z, Ghorbanzadeh B (2019) Wound healing effects of topical vitamin K: a randomized controlled trial. Indian J Pharmacol 51(2):88–92PubMedPubMedCentralCrossRef Pazyar N, Houshmand G, Yaghoobi R, Hemmati AA, Zeineli Z, Ghorbanzadeh B (2019) Wound healing effects of topical vitamin K: a randomized controlled trial. Indian J Pharmacol 51(2):88–92PubMedPubMedCentralCrossRef
51.
go back to reference Elson ML, Nacht S (1999) Treatment of periorbital hyperpigmentation with topical vitamin K/vitamin A. Cosmet Dermatol 12(27):127 Elson ML, Nacht S (1999) Treatment of periorbital hyperpigmentation with topical vitamin K/vitamin A. Cosmet Dermatol 12(27):127
52.
go back to reference Abdullah GA (2020) The effectiveness of topical vitamin K cream 1% in the treatment of steroid-induced rosacea. Res J Pharm Technol 13(8):3883–3886CrossRef Abdullah GA (2020) The effectiveness of topical vitamin K cream 1% in the treatment of steroid-induced rosacea. Res J Pharm Technol 13(8):3883–3886CrossRef
53.
go back to reference Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12(6):646–652PubMedCrossRef Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12(6):646–652PubMedCrossRef
54.
go back to reference Sharquie KE, Najim RA, Al-Salman HN (2006) Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol 45(7):857–861PubMedCrossRef Sharquie KE, Najim RA, Al-Salman HN (2006) Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study. Int J Dermatol 45(7):857–861PubMedCrossRef
55.
go back to reference Bamford JTM, Gessert CE, Haller IV, Kruger K, Johnson BP (2012) Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int J Dermatol 51(4):459–462PubMedCrossRef Bamford JTM, Gessert CE, Haller IV, Kruger K, Johnson BP (2012) Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int J Dermatol 51(4):459–462PubMedCrossRef
56.
go back to reference Sharquie KE, Noaimi AA, Al-Hashimy SA, Al-Salih MM (2014) Therapeutic evaluation of 2% tea lotion in comparison with 5% zinc sulfate solution in the treatment of acne rosacea. J Cosmet Dermatol Sci Appl 04(01):60–65 Sharquie KE, Noaimi AA, Al-Hashimy SA, Al-Salih MM (2014) Therapeutic evaluation of 2% tea lotion in comparison with 5% zinc sulfate solution in the treatment of acne rosacea. J Cosmet Dermatol Sci Appl 04(01):60–65
58.
go back to reference Andreas M, Fabczak-Kubicka A, Schwartz RA (2023) Ocular rosacea: an under-recognized entity. Ital J Dermatol Venereol 158(2):110–116CrossRef Andreas M, Fabczak-Kubicka A, Schwartz RA (2023) Ocular rosacea: an under-recognized entity. Ital J Dermatol Venereol 158(2):110–116CrossRef
59.
go back to reference Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A (2013) A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol 6(6):811–816PubMedPubMedCentral Bhargava R, Kumar P, Kumar M, Mehra N, Mishra A (2013) A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. Int J Ophthalmol 6(6):811–816PubMedPubMedCentral
60.
go back to reference Bhargava R, Chandra M, Bansal U, Singh D, Ranjan S, Sharma S (2016) A randomized controlled trial of omega 3 fatty acids in rosacea patients with dry eye symptoms. Curr Eye Res 41(10):1274–1280PubMedCrossRef Bhargava R, Chandra M, Bansal U, Singh D, Ranjan S, Sharma S (2016) A randomized controlled trial of omega 3 fatty acids in rosacea patients with dry eye symptoms. Curr Eye Res 41(10):1274–1280PubMedCrossRef
61.
go back to reference Shen S, Yan G, Cao Y, Zeng Q, Zhao J, Wang X et al (2023) Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway. Biomed Pharmacother Biomedecine Pharmacother 157:114091CrossRef Shen S, Yan G, Cao Y, Zeng Q, Zhao J, Wang X et al (2023) Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway. Biomed Pharmacother Biomedecine Pharmacother 157:114091CrossRef
Metadata
Title
The role of vitamins and nutrients in rosacea
Authors
Yanci A. Algarin
Anika Pulumati
Dana Jaalouk
Jiali Tan
Keyvan Nouri
Publication date
01-07-2024
Publisher
Springer Berlin Heidelberg
Keywords
Rosacea
Erythema
Published in
Archives of Dermatological Research / Issue 5/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-02895-4

Other articles of this Issue 5/2024

Archives of Dermatological Research 5/2024 Go to the issue